FRISON, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 135
EU - Europa 131
AS - Asia 57
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 326
Nazione #
US - Stati Uniti d'America 135
GB - Regno Unito 56
CN - Cina 55
SE - Svezia 17
IE - Irlanda 14
IT - Italia 11
FR - Francia 9
DE - Germania 7
FI - Finlandia 7
BE - Belgio 4
PL - Polonia 4
IN - India 2
AU - Australia 1
DZ - Algeria 1
EU - Europa 1
NL - Olanda 1
UA - Ucraina 1
Totale 326
Città #
Southend 52
Chandler 32
Woodbridge 30
Beijing 17
Dublin 14
Ann Arbor 12
Ashburn 12
Jinan 9
Shenyang 7
Verona 5
Brussels 4
Guangzhou 4
Hebei 4
Jacksonville 4
Lawrence 4
Princeton 4
Wilmington 4
Changsha 3
Polska 3
Düsseldorf 2
Nanjing 2
Washington 2
Bologna 1
Canberra 1
Chester 1
Dobczyce 1
Fremont 1
Fuzhou 1
Haikou 1
Hanover 1
Hefei 1
Houston 1
Jiaxing 1
Jinhua 1
Nanchang 1
New Delhi 1
Oklahoma City 1
Salsomaggiore Terme 1
San Francisco 1
Thornton Heath 1
Totale 248
Nome #
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 97
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. 84
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response 82
Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients. 71
Totale 334
Categoria #
all - tutte 1.031
article - articoli 361
book - libri 0
conference - conferenze 670
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/202045 4 4 0 0 4 7 0 6 4 3 5 8
2020/202123 1 5 1 4 5 2 0 0 0 0 3 2
2021/202231 5 9 0 3 3 0 0 2 0 0 1 8
2022/202386 4 11 6 15 7 22 2 4 11 3 1 0
2023/202428 1 5 3 3 6 8 0 1 1 0 0 0
Totale 334